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Abstract
GNAS, which encodes the stimulatory G protein α subunit (Gαs), also encodes a large variant of 
Gαs termed XLαs, and alterations in XLαs abundance or activity are implicated in various human 
disorders. Although XLαs, like Gαs, stimulates generation of the second messenger cAMP, 
evidence suggests that XLαs and Gαs have opposing effects in vivo. We investigated the role of 
XLαs in mediating signaling by parathyroid hormone (PTH), which activates a GPCR that 
stimulates both Gαs and Gαq/11 in renal proximal tubules to maintain phosphate and vitamin D 
homeostasis. At postnatal day 2 (P2), XLαs-knockout (XLKO) mice exhibited 
hyperphosphatemia, hypocalcemia, and increased serum concentrations of PTH and 1,25-
dihydroxyvitamin D, indicative of compromised PTH responsiveness. The ability of PTH to 
reduce serum phosphate concentrations was impaired and the abundance of the sodium-phosphate 
cotransporter Npt2a in renal brush-border membranes was reduced in XLKO mice, whereas PTH-
induced cAMP excretion in the urine was modestly increased. Basal and PTH-stimulated 
production of inositol trisphosphate (IP3), which is the second messenger produced by Gαq/11 
signaling, were repressed in renal proximal tubules from XLKO mice. Crossing of XLKO mice 
with mice overexpressing XLαs specifically in renal proximal tubules rescued the phenotype of 
the XLKO mice. Overexpression of XLαs in HEK 293 cells enhanced Gq/11-dependent signaling 
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SUPPLEMENTARY MATERIALS
Fig. S1. XLαs is located in the kidney at early postnatal stages and XLKO mice do not have defects in renal structure.
Fig. S2. The abundances of Npt2a protein and Slc20a2 mRNA are similar between P2 WT and XLKO mice.
Fig. S3. Increased renal Gαs abundance in P2 XLKO kidneys.
Fig. S4. The abundances of PKC-βII, PKC-θ, phosphorylated ERK1/2, and phosphorylated substrates of PKA are not decreased in the 
proximal tubules of P2 XLKO mice.
Table. S1. Sequences of the primer pairs used in qRT-PCR assays.
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in unstimulated cells and in cells stimulated with PTH or thrombin, which is a Gq/11-coupled 
receptor. Together, our findings suggest that XLαs enhances Gq/11 signaling to mediate the renal 
actions of PTH during early postnatal development.
INTRODUCTION
The α-subunit of the stimulatory heterotrimeric guanine nucleotide–binding protein (Gs) 
mediates the actions of many hormones, neurotransmitters, and autocrine or paracrine 
factors by stimulating the generation of the second messenger cyclic adenosine 
monophosphate (cAMP) (1-3). Gαs is encoded by the imprinted GNAS complex locus, 
mutations in which cause multiple genetic diseases with complex parent-of-origin–specific 
phenotypes. Furthermore, somatic mutations in GNAS that lead to constitutive Gαs activity 
or increased GNAS copy number are found in multiple benign and malignant tumors. In 
addition to Gαs, GNAS gives rise to several different gene products, including a variant of 
Gαs termed extra-large α-subunit (XLαs) (4). XLαs has a distinct N-terminal domain, but is 
otherwise identical to Gαs. Gαs is expressed biallelically in most tissues; however, paternal 
Gαs expression is silenced in some tissues, such as certain parts of the brain, thyroid, 
pituitary gland, and renal proximal tubules (5). In contrast, the XLαs promoter is silenced on 
the maternal allele and activates transcription exclusively from the paternal allele (6, 7). 
Thus, most inactivating and all activating GNAS mutations affect the expression and activity 
of XLαs when located on the paternal allele.
In mice and humans, loss of function of XLαs is implicated in intrauterine and perinatal 
growth retardation, as well as poor adaption to feeding, hypoglycemia, and disrupted 
glucose counter-regulation (8-11). Epigenetic silencing of XLαs is found in patients with a 
platelet abnormality characterized by deficient activation of the Gs-cAMP signaling 
pathway, whereas its overexpression is postulated to contribute to the development of 
chromosome 20q– amplified breast cancers (12, 13). Loss of imprinting at the XLαs 
promoter in mice, which leads to increased abundance of XLαs mRNA, also leads to early 
postnatal hypoglycemia and lethality (14). Despite the clear importance of this protein in 
multiple systems, the cellular functions of XLαs itself and relative to the functions of Gαs 
remain currently unclear. At the biochemical level, XLαs behaves similarly to Gαs and it 
stimulates G protein–coupled receptor (GPCR)–activated generation of cAMP when it is 
increased in abundance (15, 16). On the other hand, comparison of the phenotypes of XLαs 
knockout mice with those of Gαs knockout mice suggests that the two proteins play 
opposing roles in vivo, and that XLαs has actions that are distinct from those of Gαs (9, 17). 
Moreover, XLαs has several splice variants and alternative translation products (6, 18-21), 
which are also ablated or overexpressed upon genetic or epigenetic defects that alter XLαs 
expression. The relative contributions of XLαs and these other variants to physiology and 
disease pathogenesis have also remained largely unclear.
To examine the cellular roles of XLαs, we focused on the actions of parathyroid hormone 
(PTH), which acts through Gαs in the renal proximal tubule to inhibit phosphate 
reabsorption and to stimulate the synthesis of the bioactive form of vitamin D (22). PTH 
also uses the Gq/11 signaling pathway to inhibit phosphate reabsorption in the proximal 
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tubule, thus stimulating phospholipase Cβ and thereby generating the second messengers 
inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), which is followed by the 
activation of certain protein kinase C (PKC) isozymes (23). Overexpression studies have 
also shown that PTH acts through XLαs to stimulate cAMP generation (24). Because XLαs 
is found in the kidney (16, 24, 25), we investigated whether this imprinted GNAS product 
mediated the actions of PTH in vivo and whether its effects occurred through cAMP 
signaling. Our investigations showed that the loss of XLαs in the renal proximal tubule 
disrupted PTH-mediated phosphate handling during early postnatal development and, 
instead of reducing the generation of cAMP, it led to decreased Gq/11 signaling. Our 
additional studies revealed that XLαs promoted basal and agonist-stimulated Gq/11 signaling 
in transfected cells and in transgenic mice. Thus, XLαs mediates the proximal tubular 
actions of PTH and serves as a G protein α-subunit for both Gs and Gq/11-dependent 
signaling.
RESULTS
XLαs is located in renal proximal tubule cells during the early postnatal development of 
mice
XLαs protein is found in whole mouse kidneys in readily detectable amounts at postnatal 
day 2 (P2), but not P6 (25). Through immunostaining with an XLαs-specific antiserum, we 
showed that XLαs protein was located in the renal proximal tubules of P2 wild-type mice 
and, albeit less abundantly, in distal tubules, whereas no immunostaining was detected in 
other parts of the kidney (Fig. 1, A and B). XLαs protein was undetectable in samples from 
mice in which the paternal XLαs allele was disrupted (XLKO mice) (Fig. 1, A and B and 
fig. S1A). Loss of detectable XLαs protein upon ablation of the paternal allele alone is 
consistent with the exclusively paternal expression of this GNAS product, as described 
previously (6). Because XLαs mRNA abundance was greater at P2 than at later times (fig. 
S1B), we focused our efforts on determining the role of XLαs at P2. Histological analysis 
detected no obvious defects in tubule structures in P2 XLKO mice, although the kidneys 
from these mice were smaller compared to those from their wild-type littermates, consistent 
with the overall smaller size of the XLKO pups (fig. S1C) (9). Nevertheless, the abundance 
of mRNA for Kid1, which encodes a renal transcription factor whose mRNA accumulates in 
the course of postnatal renal development, was decreased by about 50% in whole kidneys 
from P2 XLKO mice compared to that in kidneys from wild-type mice, which suggests that 
there was a delay in proximal tubule development (fig. S1D).
XLKO mice exhibit hyperphosphatemia and hypocalcemia together with increased serum 
PTH
At the renal proximal tubule, PTH inhibits the reabsorption of inorganic phosphate from the 
glomerular filtrate and stimulates the synthesis of the active vitamin D metabolite 1,25 
dihydroxyvitamin D [1,25(OH)2D], which increases calcium absorption in the small 
intestine. P2 XLKO pups showed substantially increased concentrations of serum phosphate 
(hyperphosphatemia), decreased concentrations of serum calcium (hypocalcemia), as well as 
increased concentrations of serum PTH compared to wild-type mice (Table 1). However, the 
concentration of 1,25(OH)2D in the serum was also markedly increased, whereas the serum 
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concentration of fibroblast growth factor 23 (FGF23), another phosphaturic hormone that 
suppresses 1,25(OH)2D synthesis in the proximal tubule (26), was substantially reduced in 
abundance in P2 XLKO pups (Table 1).
We then examined the abundance of mRNA for renal 25-hydroxyvitamin D 1α-hydroxylase 
(Cyp27b1), which synthesizes 1,25(OH)2D, as well as that of 25-hydroxyvitamin D 24-
hydroxylase (Cyp24a1), which metabolizes 1,25(OH)2D. The abundance of Cyp27b1 
mRNA was increased >5-fold in P2 XLKO kidneys compared to that in P2 wild-type 
kidneys (Fig. 2A), whereas that of Cyp24a1 mRNA was moderately increased in P2 XLKO 
kidneys (Fig. 2B), suggesting that the increased 1,25(OH)2D abundance resulted from 
induced expression of Cyp27b1. We then examined the type II sodium-dependent phosphate 
cotransporter Npt2a in the renal brush border membrane because of its critical role in the 
reabsorption of phosphate, and we found that the abundances of its mRNA and protein in P2 
XLKO mice were markedly increased compared to those in P2 wild-type mice (Fig 2, C and 
D). In contrast, the abundances of Npt2c protein and Slc20A2 (Pit2) mRNA, which encodes 
another sodium-dependent phosphate transporter, were similar in renal brush border 
membranes from XLKO and wild-type mice, as determined by Western blotting and 
quantitative reverse transcription polymerase chain reaction (qRT-PCR) analysis, 
respectively (fig. S2, A to C).
XLKO mice are resistant to PTH despite exhibiting increased excretion of urinary cAMP
PTH stimulates the expression of Cyp27b1 by acting on its promoter region (27). As 
expected, two hours after they were injected subcutaneously (s.c.) with PTH (50 nmol/kg), 
wild-type mice exhibited a ten-fold increase in the abundance of Cyp27b1 mRNA in their 
kidneys compared to that in the kidneys of wild-type mice injected with vehicle (Fig. 3A). In 
contrast the abundance of Cyp27b1 mRNA was increased by only 1.421-fold in XLKO mice 
injected with PTH compared to that in vehicle-treated XLKO mice (Fig. 3A). Note that the 
XLKO pups had much higher basal Cyp27b1 expression than did wild-type pups (Fig. 3A). 
PTH stimulates renal phosphate excretion by decreasing the abundance of Npt2a protein in 
renal brush border membranes and thus leads to hypophosphatemia (28). After they were 
injected with PTH, P2 wild-type mice had statistically significantly reduced serum 
phosphate concentrations compared to those in vehicle-treated wild-type mice, whereas the 
serum phosphate concentration of PTH-treated XLKO mice was not substantially reduced 
compared to that in vehicle-treated XLKO mice (Fig. 3B). Similarly divergent effects of 
PTH on renal Npt2a abundance in wild-type and XLKO mice were also observed (Fig. 3, C 
and D). Fifteen minutes after they were injected with PTH, wild-type mice showed an 80% 
decrease in the abundance of Npt2a in the renal brush border membrane compared to that in 
vehicle-treated wild-type mice, whereas the effect of PTH on reducing Npt2a abundance in 
the renal brush border membranes of XLKO mice was less substantial (Fig. 3, C to E). 
These results suggest that the proximal tubular actions of PTH in XLKO mice were blunted 
compared to those in wild-type mice.
To characterize the role of XLαs in mediating the actions of PTH, we tested whether XLKO 
exhibited a reduction in the PTH-induced secretion of cAMP from the kidney into the urine; 
a test that is used to assess the proximal tubular action of PTH and to establish a diagnosis of 
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PTH resistance in patients (29). The basal concentrations of urinary cAMP in P2 wild-type 
and XLKO mice were similar 15 min after they received s.c. injections of vehicle (Fig. 4A). 
Injection with PTH led to increased concentrations of urinary cAMP in wild-type and 
XLKO pups; however, the concentrations were statistically significantly greater in the 
XLKO mice than in their wild-type littermates (Fig. 4A). We then measured Gαs mRNA 
abundance in whole kidneys and found a moderate, but statistically significant, increase in 
those of P2 XLKO mice compared to those of wild-type mice (Fig. 4B). Western blotting 
analysis revealed a three-fold increase in the abundance of Gαs protein in the brush border 
membranes of XLKO mice compared to that in the brush border membranes of wild-type 
mice (Fig. 4, C and D). Immunostaining of kidney sections with anti-serum directed against 
the unique N-terminal portion of Gαs (and that cannot recognize XLαs) was also suggestive 
of increased amounts of Gαs protein in the kidneys of XLKO mice (fig. S3).
XLKO pups show repressed Gq/11 signaling
Because the PTH-stimulated generation of cAMP was not impaired in P2 XLKO mice, we 
examined the Gq/11 signaling pathway, which can be activated by PTH and contributes to 
the regulation of serum phosphate concentrations (23, 30, 31). In proximal tubule–enriched 
renal cortices isolated from P2 XLKO kidneys, we found that the intracellular amount of the 
IP3 metabolite inositol monophosphate (IP1), which reflects IP3 generation, was 
substantially reduced under basal conditions, as well as upon stimulation with PTH (Fig. 
5A). Western blotting analysis showed that the abundances of PKCδ, PKCα, and PKCζ, but 
not PKCβII or PKCθ, were decreased in the cytosolic fractions of XLKO samples compared 
to those in cytosolic fractions of samples from wild-type mice (Fig. 5B and fig. S4, A and 
B). PKCδ abundance was also markedly decreased in the membrane fractions of XLKO 
samples, whereas the abundances of PKCα and PKCζ were only slightly reduced (Fig. 5, B 
to E). Moreover, the abundances of PKCδ, PKCα, and PKCζ after PTH treatment were 
substantially decreased in both the cytosolic and membrane fractions of XLKO samples 
compared to those of wild-type samples (Fig. 5, B to E). Western blotting analysis indicated 
no reduction in the abundance of phosphorylated extracellular signal–regulated kinase 1 
(ERK1) and ERK2 in the proximal tubules from XLKO mice either under basal conditions 
or after stimulation with PTH (fig. S4, C and D), whereas the amounts of phosphorylated 
PKA targets were slightly increased in membrane fractions after stimulation with PTH (Fig. 
5B and fig. S4E).
Hyperphosphatemia and reduced Gq/11 signaling in XLKO mice are rescued by 
overexpression of XLαs specifically in proximal tubules
Knockout of the gene encoding XLαs in XLKO mice ablates not only XLαs, but also its 
variants in all tissues (9). To determine whether the proximal tubule–specific overexpression 
of XLαs could rescue the hyperphosphatemia phenotype of P2 XLKO mice, we crossed 
XLKO mice to transgenic mice in which XLαs expression was targeted to the renal 
proximal tubule with the promoter of the gene encoding the type I rat γ-
glutamyltranspeptidase promoter (rptXLαs mice) (25). We found that this promoter was 
active at the P2 stage and that the abundance of XLαs mRNA in rptXLαs mice was 12-fold 
higher than that in wild-type littermates (Fig. 6A). Whereas the XLKO offspring from these 
matings showed hyperphosphatemia, rptXLαs offspring tended to have reduced 
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concentrations of serum phosphate (Fig. 6B). Serum phosphate concentrations were 
statistically significantly lower in the XLKO:rptXLαs offspring than in the XLKO offspring, 
and these concentrations were comparable to those in wild-type littermates (Fig. 6B). In 
addition, the increase in Cyp27b1 expression observed in XLKO mice was effectively 
reversed by transgenic overexpression of XLαs (Fig. 6C), although the expression of 
Cyp24a1 was still increased in the XLKO:rptXLαs mice (Fig. 6D). The reduced abundance 
of Kid1 mRNA in XLKO mice was also fully rescued by overexpression of XLαs in 
proximal tubules (Fig. 6E). Western blotting analysis revealed that the reduction in the 
abundances of PKCδ, PKCα, and PKCζ in the proximal tubules of XLKO mice was also 
rescued by the proximal tubule–specific overexpression of XLαs (Fig. 6, F to I). In 
particular, overexpression of XLαs in the proximal tubule substantially increased the 
membrane abundance of PKCδ, which was evident in both rptXLαs and XLKO:rptXLαs 
pups (Fig. 6, F and G).
XLαs expression enhances the basal and agonist-stimulated amounts of IP1
Basal and PTH-stimulated concentrations of IP1 were statistically significantly increased in 
proximal tubule–enriched cortices isolated from P2 rptXLαs mice compared to those in 
similar cortices isolated from wild-type littermates (Fig. 7A). Concordant with these results, 
transient transfection of human embryonic kidney (HEK) 293 cells stably expressing the 
PTH receptor with increasing amounts of plasmid encoding XLαs resulted in a dose-
dependent increase in basal IP1 concentrations (Fig. 7B). Moreover, cells transfected with 
either control plasmid or plasmid encoding XLαs responded to PTH, but the overexpression 
of XLαs substantially enhanced the generation of IP1 in response to different concentrations 
of PTH (Fig. 7C). Furthermore, overexpression of XLαs in these cells also enhanced the 
amount of IP1 generated in response to thrombin, another agonist that acts through its own 
endogenous Gq-coupled receptor (Fig. 7D). In addition, we examined a guanosine 
triphosphatase (GTPase) deficient mutant of XLαs (XLαs-R543H), which shows 
constitutive activity with respect to cAMP generation (24). As expected, HEK 293 cells 
transiently expressing this mutant XLαs displayed increased basal cAMP generation 
compared to those cells expressing wild-type XLαs (Fig. 7E). Similarly, basal IP1 
concentrations were substantially greater in HEK 293 cells expressing XLαs-R543H than in 
those expressing wild-type XLαs (Fig. 7F).
To determine whether XLαs could mimic the actions of Gq/11 proteins, we expressed XLαs 
in HEK 293 cells in which Gq and G11 were both ablated through the use of the CRISPR 
(clustered regularly interspaced short palindromic repeats)/Cas9 system(CRISPR-
associated). Thrombin stimulated a 2.55-fold increase in IP1 generation in native HEK 293 
cells compared to that in unstimulated cells (Fig. 7G), whereas it failed to stimulate IP1 
generation in Gq/11-deficient HEK 293 cells that were transfected with control plasmid (Fig. 
7H). Transient transfection of the Gq/11-deficient HEK 293 cells with plasmid encoding 
either Gαq or Gα11 led to an increase in basal IP1 concentrations and rescued the thrombin-
stimulated generation of IP1 (Fig 7H). In Gq/11-deficient HEK 293 cells transfected with 
plasmid encoding XLαs, the basal IP1 concentration was 3.39-fold greater than that in cells 
transfected with the control plasmid, and thrombin stimulated a 1.81-fold increase in IP1 
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abundance compared to that in unstimulated Gq/11-deficient cells expressing XLαs (Fig. 
7H).
DISCUSSION
We investigated the role of XLαs, a variant of Gαs, by focusing on the action of PTH, and 
our data suggest that XLαs is essential for the PTH-mediated regulation of phosphate-
handling in the renal proximal tubule during early postnatal development. Whereas this role 
of XLαs appears to be similar to that of Gαs in the same context, we found that the ablation 
of XLαs in mice repressed Gq/11-mediated signaling rather than Gs-mediated signaling. Our 
additional results suggest that XLαs promotes basal and agonist-stimulated signaling by 
Gq/11 proteins.
By stimulating at least two signaling pathways, which are mediated by Gs and Gq/11 
proteins, PTH inhibits renal phosphate reabsorption by decreasing the abundance of Npt2a 
protein. The hyperphosphatemia in XLKO mice is thus consistent with an increase in the 
amount of Npt2a at steady-state and the blunted PTH-induced reduction in Npt2a 
abundance. FGF23 also decreases the abundance of Npt2a (32), and therefore, the increased 
Npt2a abundance would be consistent with the reduction in the amount of FGF23 in XLKO 
mice. However, a role for reduced FGF23 in P2 XLKO mice is unlikely because complete 
ablation of FGF23 in mice does not lead to alterations in serum phosphate and calcium 
concentrations until after P6 (33, 34). PTH also increases the synthesis of 1,25(OH)2D by 
inducing the expression of Cyp27b1, but this effect depends largely on Gs-dependent 
signaling (27, 35). Because the serum PTH concentration was increased in XLKO pups 
compared to that in wild-type pups, and because this was concurrent with markedly 
increased amounts of renal Cyp27b1 mRNA and 1,25(OH)2D, it is possible that the action of 
PTH on Cyp27b1 expression is somewhat preserved in the absence of XLαs. In support of 
this possibility was the tendency of renal Cyp27b1 mRNA abundance to increase even more 
than the already enhanced amounts in response to PTH in XLKO pups (Fig. 4A). A 
reduction in the amount serum FGF23 is unlikely to account for the increased amount of 
1,25(OH)2D in P2 XLKO pups, because FGF23-deficient mice do not display increased 
amounts of 1,25(OH)2D until after P10 (33). 1,25(OH)2D stimulates the expression of 
Cyp24a1, which would thus explain the increased renal abundance of Cyp24a1 mRNA in 
XLKO pups.
The hypocalcemia in XLKO pups is more difficult to explain, given their increased amounts 
of 1,25(OH)2D, which normally enhances Ca2+ absorption in the gut. In newborns, however, 
deficiency in 1,25(OH)2D or the loss of its receptor does not lead to hypocalcemia, which 
suggests that this hormone is not essential for regulating serum Ca2+ concentrations during 
early postnatal life (36). It is possible that the reduced serum concentration of Ca2+ in 
XLKO pups is secondary to hyperphosphatemia or reflects the poor feeding of the XLKO 
pups (9). In addition, PTH enhances the reabsorption of Ca2+ in the renal distal tubule (22). 
Because we detected XLαs protein in this part of the nephron, PTH-induced reabsorption of 
Ca2+ may be impaired in P2 XLKO mice, thus contributing to the hypocalcemia despite the 
presence of increased amounts of PTH in the serum of these mice.
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The PTH resistance in XLKO pups was observed in the presence of intact, and modestly 
increased, Gαs abundance and an enhanced PTH-stimulated cAMP response. In contrast, 
basal and PTH-stimulated IP3 signaling and the abundances of certain PKC isoforms were 
repressed. In addition, overexpression of XLαs in the proximal tubules of XLKO pups 
rescued both the hyperphosphatemia and the diminished generation of IP1. It thus appears 
that the impaired responsiveness of Npt2a to PTH in the proximal tubules of XLKO mice, 
and the resultant changes in serum biochemistries of XLKO pups, are at least partly a result 
of the impaired activation of IP3-DAG signaling. Together with the results of our cell culture 
experiments, these findings suggest that XLαs serves as a Gαq/11-like signaling protein and 
that it mediates the PTH-induced inhibition of phosphate reabsorption from the glomerular 
filtrate. Previous studies showed that the Gq/11 signaling pathway and the activation of PKC 
play crucial roles in the PTH-stimulated internalization of Npt2a and regulation of 
phosphate homeostasis (37-39). Our findings confirm the importance of this signaling 
pathway to the renal actions of PTH, and they identify XLαs as an indispensable mediator of 
those actions during early postnatal development. Given that XLKO mice that survive to 
weaning show normal concentrations of phosphate, Ca2+, and PTH in the serum (14), the 
phenotypes of XLKO pups are similar to the clinical findings of patients with transient 
neonatal pseudohypoparathyroidism, who show hypocalcemia, hyperphosphatemia, and 
increased serum PTH concentrations during early postnatal life (40, 41). Whether these 
patients have mutations in exon 1 of their paternal GNAS XLαs or in genes encoding the 
signaling partners of XLαs should be investigated.
Despite having increased serum PTH concentrations and Gαs protein abundance in renal 
brush border membranes, XLKO mice had baseline urinary cAMP concentrations that were 
indistinguishable from those of wild-type mice. This finding may reflect a lack of sensitivity 
of our cAMP measurement assay. Alternatively, XLKO pups may have developed adaptive 
changes to prevent increases in urinary cAMP concentration at steady-state, such as 
desensitization of the mechanism responsible for the efflux of cAMP into the urine. The 
quantities of phosphorylated PKA substrates in the proximal tubules of unstimulated XLKO 
and wild-type mice were similar, suggesting that other adaptive changes may have occurred, 
such as in the relative amounts of cAMP phosphodiesterases (Fig. 5 and fig. S4E). In 
contrast, phosphorylated PKA substrates were substantially more abundant in the proximal 
tubule membranes of PTH-stimulated XLKO mice than in those of PTH-stimulated wild-
type mice. It is possible that the exchange protein activated by cAMP (Epac) is also 
activated more robustly in the proximal tubules of XLKO mice than in the proximal tubules 
of wild-type mice, particularly after receptor stimulation. Epac plays important roles in 
proximal tubules through its stimulation of ERK1/2 signaling (42, 43); however, the 
abundance of phosphorylated ERK1/2 was not altered in the proximal tubules of XLKO 
mice (fig. S4, C and D). Moreover, a study suggests that Epac activation is not involved in 
renal phosphate-handling or the regulation of Npt2a (44), arguing against the possibility that 
enhanced Epac activity contributes to the hyperphosphatemia observed in XLKO pups.
Consistent with the marked identity between the amino acid sequences of XLαs and Gαs, in 
vitro overexpression experiments indicate that XLαs stimulates both basal and receptor-
activated generation of cAMP (24, 25); however, no cAMP-independent cellular functions 
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have hitherto been assigned to XLαs. Our study suggests that even though it is a Gαs-like 
protein, XLαs promotes the Gq/11 signaling pathway in vivo. Thus, the GNAS complex locus 
presents an interesting paradigm in which a single gene encoding a G protein α-subunit 
encodes partially identical products that stimulate two different G protein– mediated 
pathways. Unlike in the regulation of PTH-mediated phosphate-handling, the Gs- and Gq/11-
dependent signaling pathways mediate opposing responses in many tissues, such as platelets 
and airway smooth muscles (45, 46). Consistent with these actions, previous studies have 
indicated that Gαs and XLαs have opposing roles in vivo (17, 47).
The effect of XLαs on Gq/11 signaling and PKC isoform abundance could be developmental, 
but our experiments with transiently transfected cells suggest that XLαs directly enhances 
the activation of PLC-β. Moreover, results from experiments with the GTPase-deficient 
XLαs mutant, which is analogous to the Gαs mutant R201H that is found in multiple benign 
and malignant tumors (3), indicate that this action of XLαs is also limited by its intrinsic 
GTPase activity. In addition, our findings obtained from experiments with Gq/11-deficient 
cells suggest that XLαs stimulates IP3 generation at least partly by mimicking the actions of 
Gαq and Gα11. It could be argued that XLαs promotes the Gq/11 signaling pathway by 
increasing the abundance of cAMP, because cAMP signaling in some cells can stimulate 
certain PLC isozymes (48). In overexpression experiments, a similar mechanism could 
perhaps be involved in the XLαs-mediated generation of IP3, particularly under basal 
conditions; however, thrombin receptors do not couple to Gs proteins (49), and therefore 
thrombin-induced IP3 generation in XLαs-expressing, Gq/11-deficient cells is unlikely to be 
secondary to cAMP generation. Our findings from in vivo experiments also argue against 
the involvement of a cAMP-dependent mechanism, because XLKO pups showed increased 
PTH-stimulated generation of cAMP in the proximal tubule despite having diminished 
Gq/11-mediated signaling.
PKCs are divided into three subfamilies: conventional, novel, and atypical. Conventional 
PKCs, such as PKCα, and novel PKCs, such as PKCδ, require DAG for their activation, and 
are thus downstream of Gq/11 signaling (50). The inhibited generation of IP3, as well as the 
decreased abundances of PKCδ and PKCα, in the proximal tubules of P2 XLKO mice 
suggest that XLαs plays a stimulatory role in Gq/11 signaling. On the other hand, PKCζ, 
which is an atypical PKC that does not require DAG or Ca2+ for activation (51), was also 
reduced in abundance in samples from XLKO mice, suggesting that XLαs might also 
regulate the abundance of atypical PKCs through an as-yet-undefined mechanism. PTH 
stimulates PKC activation in a PLC-independent manner (52), which might possibly be 
mediated by XLαs.
That loss of XLαs increased the PTH-stimulated generation of cAMP is consistent with data 
from experiments with brown adipose tissue (BAT) from XLKO mice, in which basal and 
isoproterenol-stimulated cAMP generation were enhanced compared to those in BAT from 
wild-type mice (9). Our results suggest that the increased production of cAMP in the 
proximal tubules of XLKO mice is at least partly a result of increased Gαs abundance. It is 
tempting to speculate that the changes in Gαs abundance reflect a physiological response to 
help counteract the hyperphosphatemia. The change in Gαs abundance in proximal tubules 
from XLKO mice may also result from the loss of a potential regulatory mechanism 
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involving an interaction in cis between the paternal XLαs transcript and the downstream Gαs 
promoter, because a similar mechanism involving another paternally expressed upstream 
GNAS transcript (A/B) and the Gαs promoter has been proposed (53).
GNAS is a highly complex locus, and XLαs itself has multiple variants and alternative 
translational products (6, 18-21). The XLKO mice have a deletion in extra-large exon 1, thus 
ablating all of these variants (9). Thus, the PTH-resistant phenotype of XLKO pups could 
reflect n a deficiency in one or more of these proteins. However, the phenotype was rescued 
by overexpressing XLαs in the proximal tubule, and it is therefore likely that the phenotype 
reflects a specific deficiency in XLαs, rather than its other variants, in this tissue. Note that 
the XLKO:rptXLαs pups appeared grossly indistinguishable from their XLKO littermates 
and showed a similar degree of early postnatal lethality, indicating that other XLαs variants 
could be responsible for these other defects.
In summary, our study revealed a hitherto unknown function of the large Gαs variant XLαs, 
demonstrating that this imprinted protein can enhance the Gq/11 signaling pathway. Our 
studies with XLαs-deficient mice also suggest that XLαs is required for the action of PTH in 
the proximal tubules of early postnatal mice with respect to phosphate-handling. These 
findings have broad implications regarding the pathogenesis of human diseases caused by 
GNAS mutations or copy number variations.
MATERIALS AND METHODS
Mice
XLKO mice and rptXLαs mice (9, 25) were maintained in a CD1 genetic background. All 
the animal experiments were conducted in accordance with the accepted standards of the 
Institutional Animal Care and Use Committee, and the studies were approved by the 
Massachusetts General Hospital Subcommittee on Research Animal Care.
Expression plasmids
Construction of plasmids encoding XLαs and the GTPase-deficient XLαs mutant XLαs-
R543H was described previously (20, 24). Plasmids encoding Gαq and Gα11 plasmids were 
obtained from cDNA.org.
cDNA synthesis and qRT-PCR analysis
Total RNA isolated from the kidneys of P2 WT, XLKO, rptXLαs, and XLKO:rptXLαs mice 
was prepared with the RNeasy Plus Mini Kit (Qiagen), and cDNA was synthesized with the 
ProtoScript II First stand cDNA synthesis kit (New England Biolabs) as previously 
described (54). qRT-PCR analysis was performed with specific primers (table S1) and 
FastStart Universal SYBR Green Master (Roche) with Actb (β-actin) as a reference gene.
Immunofluorescence microscopy
Kidneys were isolated from P2 XLKO and WT littermates, fixed, and serially sectioned at 5 
μm. Sections were incubated with polyclonal antiserum against mouse XLαs (25) at a 1:500 
dilution, antibody specific for the N-terminal region of Gαs encoded by exon 1 (1:500) (a 
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gift of S. Mollner, Germany) (4), or antibody against Calbindin D-28K (Sigma) at 4°C 
overnight. Sections were then incubated with Alexa Fluor 568–conjugated donkey anti-
rabbit antibody and Alexa Fluor 488–conjugated phalloidin, or with Alexa Fluor 488–
conjugated goat anti-mouse antibody (Life technologies) at room temperature for one hour 
(24). Immunoreactivity was visualized and analyzed with a Zeiss LSM 510 Confocal 
Microscope and Zeiss Zen software.
Measurement of serum biochemistries
Blood samples for the analysis of serum concentrations of phosphate, Ca2+, PTH, and 
1,25(OH)2D were obtained from the carotid artery and were processed as described 
previously (25). Serum FGF23 concentrations were measured with the Mouse/Rat FGF-23 
(C-Term) ELISA kit (Immutopics). To determine the effect of PTH on cAMP generation in 
vivo, urine was collected 15 min after mice were injected s.c. with vehicle or PTH(1-34) (50 
nmol/kg), and the concentration of cAMP was quantified as described previously (14). The 
PTH-induced reduction in the concentration of serum phosphate was measured two hours 
after mice were injected with PTH(1-34) or vehicle as previously described (25).
Isolation and Western blotting analysis of renal brush border membranes
Brush border membrane portions were isolated from the kidneys of P2 mice as described 
previously (55) with minor modifications. Isolated brush border membrane proteins were 
lysed in a Tris-buffered solution containing 150 mM NaCl and 1% Triton and a protease 
inhibitor cocktail (Roche). Measurement of protein concentrations in the samples and 
Western blotting analysis with antibodies specific for Npt2a, Npt2c (56), and Gαs 
(Millipore) were performed as described previously (25).
Isolation of proximal tubule–enriched cortices and IP1 assays
Proximal tubule–enriched renal cortices were prepared by collagenase digestion of P2 
mouse kidneys and isolation on a Percoll gradient as described previously (57). Proximal 
tubules from P2 WT, XLKO, or rptXLαs mice were treated with different concentrations of 
PTH(1-34) for 30 minutes in the presence of LiCl2 and then were analyzed to determine the 
amount of IP1, a downstream metabolite of IP3, with the IP1 HTRF assay kit (Cisbio). HEK 
293 cells stably expressing the PTHR (a gift of T. Gardella, MGH) were transfected with 
plasmids encoding XLαs or XLαs-R543H and incubated for 30 min in the presence or 
absence of PTH(1-34) before IP1 concentrations were measured. Parental WT and Gαq/11–/– 
HEK 293 cells (a gift of A. Inoue, Tohoku University) were transfected with pcDNA or 
plasmids encoding XLαs, Gαq, or Gα11 and then incubated for 30 min in the presence or 
absence of thrombin before IP1 concentrations were measured.
cAMP signaling assays
Signaling through the cAMP and PKA pathway was assessed in experiments with HEK 293 
cells stably transfected with the Glosensor cAMP reporter plasmid and with plasmid 
encoding PTHR and then transiently transfected with plasmids encoding XLαs or XLαs-
R543H. For assays, confluent cells in 96-well plates were treated with luciferin and 2 mM 
He et al. Page 11
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
IBMX (3-isobutyl-1-methylxanthine) for 30 min before luminescence was measured as 
previously described (58).
Cell fractionation and analysis of PKC isoforms
Proximal tubule–enriched renal cortices were subjected to cell fractionation by 
ultracentrifuge to separate cytosolic and membrane fractions (59). Protein lysates were 
resolved by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to 
nitrocellulose membranes (Bio-rad). Western blots were then incubated with antibodies 
directed against specific PKC isoforms, phosphorylated substrates of PKA, and 
phosphorylated ERK1/2 (Cell signaling). Antibodies against actin (Santa Cruz) and the Na-
K ATPase (Cell signaling) were used to identify cytosolic and membrane fractions. 
Densitometric analysis of Western blots was performed with ImageJ software.
Statistical analysis
The means ± SEM of multiple independent measurements were calculated. To determine 
statistical significance, Leven's F-test was first performed to assess equality of variances. If 
variances were equal, the Student's t-test (two-tailed) assuming equal variance was used for 
comparing two means, whereas one-way ANOVA followed by Tukey's multiple comparison 
test was used for comparing three or more groups. Welch's t-test (two-tailed) was used for 
comparisons between two means with unequal variances. The same test was used for 
multiple comparisons involving groups with unequal variances, followed by Bonferroni 
correction (that is, P values were multiplied by the number of comparisons). Statistical 
significance is represented as follows: *P < 0.05, **P < 0.01, ***P < 0.001.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank T. Gardella and H. Jüppner (MGH) for insightful discussions and H. M. Kronenberg (MGH) for critically 
reviewing the manuscript. The abundance of IP1 was measured at the Massachusetts General Hospital Endocrine 
Unit Center for Skeletal Research, Bone Cell and Signaling Core. Human PTH (1–34) was synthesized by the 
Peptide/Protein Core Facility at Massachusetts General Hospital. Funding: This work was conducted with support 
from Harvard Catalyst: The Harvard Clinical and Translational Science Center (National Center for Research 
Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 
TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The 
studies were funded in part by a research grant from NIH/NIDDK (RO1DK073911 to M.B.). The Massachusetts 
General Hospital Endocrine Unit Center for Skeletal Research was funded by a grant from NIH/NIAMS (P30 
AR066261).
REFERENCES and NOTES
1. Turan S, Bastepe M. The GNAS complex locus and human diseases associated with loss-of-function 
mutations or epimutations within this imprinted gene. Horm Res Paediatr. 2013; 80:229–41. 
[PubMed: 24107509] 
2. Plagge A, Kelsey G, Germain-Lee EL. Physiological functions of the imprinted Gnas locus and its 
protein variants Galpha(s) and XLalpha(s) in human and mouse. J Endocrinol. 2008; 196:193–214. 
[PubMed: 18252944] 
He et al. Page 12
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
3. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-
subunit mutations and the role of genomic imprinting. Endocr Rev. 2001; 22:675–705. [PubMed: 
11588148] 
4. Kehlenbach RH, Matthey J, Huttner WB. XL alpha s is a new type of G protein. Nature. 1994; 
372:804–9. [PubMed: 7997272] 
5. Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria Z, Accili D, Westphal H, Weinstein LS. Variable and 
tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout 
mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci U S A. 1998; 
95:8715–20. [PubMed: 9671744] 
6. Hayward BE, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron DT. The 
human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G 
proteins. Proc Natl Acad Sci U S A. 1998; 95:10038–43. [PubMed: 9707596] 
7. Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, Beechey CV, Williamson CM, Kelsey G. A 
cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse 
chromosome 2. Proc Natl Acad Sci U S A. 1999; 96:3830–5. [PubMed: 10097123] 
8. Richard N, Molin A, Coudray N, Rault-Guillaume P, Juppner H, Kottler ML. Paternal GNAS 
mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of 
XLalphas in fetal development. J Clin Endocrinol Metab. 2013; 98:E1549–56. [PubMed: 23884777] 
9. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G. The imprinted signaling protein 
XL alpha s is required for postnatal adaptation to feeding. Nat Genet. 2004; 36:818–26. [PubMed: 
15273686] 
10. Genevieve D, Sanlaville D, Faivre L, Kottler ML, Jambou M, Gosset P, Boustani-Samara D, Pinto 
G, Ozilou C, Abeguile G, Munnich A, Romana S, Raoul O, Cormier-Daire V, Vekemans M. 
Paternal deletion of the GNAS imprinted locus (including Gnasxl) in two girls presenting with 
severe pre- and post-natal growth retardation and intractable feeding difficulties. Eur J Hum 
Genet. 2005; 13:1033–9. [PubMed: 15915160] 
11. Aldred MA, Aftimos S, Hall C, Waters KS, Thakker RV, Trembath RC, Brueton L. Constitutional 
deletion of chromosome 20q in two patients affected with albright hereditary osteodystrophy. Am 
J Med Genet. 2002; 113:167–72. [PubMed: 12407707] 
12. Izzi B, Francois I, Labarque V, Thys C, Wittevrongel C, Devriendt K, Legius E, Van den Bruel A, 
D'Hooghe M, Lambrechts D, de Zegher F, Van Geet C, Freson K. Methylation defect in imprinted 
genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet 
Gs hypofunction. PLoS One. 2012; 7:e38579. [PubMed: 22679513] 
13. Garcia-Murillas I, Sharpe R, Pearson A, Campbell J, Natrajan R, Ashworth A, Turner NC. An 
siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer. Oncogene. 
2014; 33:2478–86. [PubMed: 23752180] 
14. Fernandez-Rebollo E, Maeda A, Reyes M, Turan S, Frohlich LF, Plagge A, Kelsey G, Juppner H, 
Bastepe M. Loss of XLalphas (extra-large alphas) imprinting results in early postnatal 
hypoglycemia and lethality in a mouse model of pseudohypoparathyroidism Ib. Proc Natl Acad 
Sci U S A. 2012; 109:6638–43. [PubMed: 22496590] 
15. Klemke M, Pasolli HA, Kehlenbach RH, Offermanns S, Schultz G, Huttner WB. Characterization 
of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J Biol 
Chem. 2000; 275:33633–40. [PubMed: 10931851] 
16. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, Juppner H. Receptor-
mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory 
G protein alpha-subunit. Mol Endocrinol. 2002; 16:1912–9. [PubMed: 12145344] 
17. Xie T, Plagge A, Gavrilova O, Pack S, Jou W, Lai EW, Frontera M, Kelsey G, Weinstein LS. The 
alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and 
glucose metabolism and sympathetic nerve activity in adult mice. J Biol Chem. 2006; 281:18989–
99. [PubMed: 16672216] 
18. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, Huttner WB. Characterization of the extra-large 
G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J Biol Chem. 
2000; 275:33622–32. [PubMed: 10931823] 
He et al. Page 13
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
19. Klemke M, Kehlenbach RH, Huttner WB. Two overlapping reading frames in a single exon 
encode interacting proteins--a novel way of gene usage. EMBO J. 2001; 20:3849–60. [PubMed: 
11447126] 
20. Aydin C, Aytan N, Mahon MJ, Tawfeek HA, Kowall NW, Dedeoglu A, Bastepe M. Extralarge 
XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a 
distinct, membrane-anchored GNAS product that can mimic Gs(alpha). Endocrinology. 2009; 
150:3567–75. [PubMed: 19423757] 
21. Abramowitz J, Grenet D, Birnbaumer M, Torres HN, Birnbaumer L. XLalphas, the extra-long 
form of the alpha-subunit of the Gs G protein, is significantly longer than suspected, and so is its 
companion Alex. Proc Natl Acad Sci U S A. 2004; 101:8366–71. [PubMed: 15148396] 
22. Kronenberg, H.; Williams, RH. Williams textbook of endocrinology. Saunders/Elsevier; 
Philadelphia: 2008. p. xixp. 1911
23. Bringhurst FR, Juppner H, Guo J, Urena P, Potts JT Jr. Kronenberg HM, Abou-Samra AB, Segre 
GV. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate 
multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology. 
1993; 132:2090–8. [PubMed: 8386606] 
24. Liu Z, Turan S, Wehbi VL, Vilardaga JP, Bastepe M. Extra-long Galphas variant XLalphas protein 
escapes activation-induced subcellular redistribution and is able to provide sustained signaling. J 
Biol Chem. 2011; 286:38558–69. [PubMed: 21890629] 
25. Liu Z, Segawa H, Aydin C, Reyes M, Erben RG, Weinstein LS, Chen M, Marshansky V, Frohlich 
LF, Bastepe M. Transgenic overexpression of the extra-large Gsalpha variant XLalphas enhances 
Gsalpha-mediated responses in the mouse renal proximal tubule in vivo. Endocrinology. 2011; 
152:1222–33. [PubMed: 21303955] 
26. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, 
Fukumoto S, Yamashita T. FGF-23 is a potent regulator of vitamin D metabolism and phosphate 
homeostasis. J Bone Miner Res. 2004; 19:429–35. [PubMed: 15040831] 
27. Brenza HL, Kimmel-Jehan C, Jehan F, Shinki T, Wakino S, Anazawa H, Suda T, DeLuca HF. 
Parathyroid hormone activation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene promoter. 
Proc Natl Acad Sci U S A. 1998; 95:1387–91. [PubMed: 9465024] 
28. Murer H, Lotscher M, Kaissling B, Levi M, Kempson SA, Biber J. Renal brush border membrane 
Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int. 1996; 
49:1769–73. [PubMed: 8743494] 
29. Chase LR, Melson GL, Aurbach GD. Pseudohypoparathyroidism: defective excretion of 3′,5′-
AMP in response to parathyroid hormone. J Clin Invest. 1969; 48:1832–44. [PubMed: 4309802] 
30. Dunlay R, Hruska K. PTH receptor coupling to phospholipase C is an alternate pathway of signal 
transduction in bone and kidney. Am J Physiol. 1990; 258:F223–31. [PubMed: 2155534] 
31. Guo J, Song L, Liu M, Segawa H, Miyamoto K, Bringhurst FR, Kronenberg HM, Juppner H. 
Activation of a non-cAMP/PKA signaling pathway downstream of the PTH/PTHrP receptor is 
essential for a sustained hypophosphatemic response to PTH infusion in male mice. 
Endocrinology. 2013; 154:1680–9. [PubMed: 23515284] 
32. Gattineni J, Bates C, Twombley K, Dwarakanath V, Robinson ML, Goetz R, Mohammadi M, 
Baum M. FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia 
in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009; 297:F282–91. 
[PubMed: 19515808] 
33. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka 
K, Yamashita T. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 
in phosphate and vitamin D metabolism. J Clin Invest. 2004; 113:561–8. [PubMed: 14966565] 
34. Ma Y, Samaraweera M, Cooke-Hubley S, Kirby BJ, Karaplis AC, Lanske B, Kovacs CS. Neither 
absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal 
skeletal development and mineralization. Endocrinology. 2014; 155:1596–605. [PubMed: 
24601885] 
35. Murayama A, Takeyama K, Kitanaka S, Kodera Y, Kawaguchi Y, Hosoya T, Kato S. Positive and 
negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid 
He et al. Page 14
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals. Endocrinology. 1999; 140:2224–
31. [PubMed: 10218975] 
36. Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and 
clinical studies. Annu Rev Nutr. 2012; 32:97–123. [PubMed: 22483092] 
37. Capuano P, Bacic D, Roos M, Gisler SM, Stange G, Biber J, Kaissling B, Weinman EJ, Shenolikar 
S, Wagner CA, Murer H. Defective coupling of apical PTH receptors to phospholipase C prevents 
internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice. Am J 
Physiol Cell Physiol. 2007; 292:C927–34. [PubMed: 16987995] 
38. Traebert M, Volkl H, Biber J, Murer H, Kaissling B. Luminal and contraluminal action of 1-34 and 
3-34 PTH peptides on renal type IIa Na-P(i) cotransporter. Am J Physiol Renal Physiol. 2000; 
278:F792–8. [PubMed: 10807591] 
39. Forster IC, Hernando N, Biber J, Murer H. Proximal tubular handling of phosphate: A molecular 
perspective. Kidney Int. 2006; 70:1548–59. [PubMed: 16955105] 
40. Minagawa M, Yasuda T, Kobayashi Y, Niimi H. Transient pseudohypoparathyroidism of the 
neonate. Eur J Endocrinol. 1995; 133:151–5. [PubMed: 7655638] 
41. Manzar S. Transient pseudohypoparathyroidism and neonatal seizure. J Trop Pediatr. 2001; 
47:113–4. [PubMed: 11336128] 
42. Carraro-Lacroix LR, Malnic G, Girardi AC. Regulation of Na+/H+ exchanger NHE3 by glucagon-
like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Renal 
Physiol. 2009; 297:F1647–55. [PubMed: 19776173] 
43. Lee YJ, Kim MO, Ryu JM, Han HJ. Regulation of SGLT expression and localization through 
Epac/PKA-dependent caveolin-1 and F-actin activation in renal proximal tubule cells. Biochim 
Biophys Acta. 2012; 1823:971–82. [PubMed: 22230192] 
44. Honegger KJ, Capuano P, Winter C, Bacic D, Stange G, Wagner CA, Biber J, Murer H, Hernando 
N. Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein 
directly activated by cAMP (EPAC). Proc Natl Acad Sci U S A. 2006; 103:803–8. [PubMed: 
16407144] 
45. Brass LF, Hoxie JA, Kieber-Emmons T, Manning DR, Poncz M, Woolkalis M. Agonist receptors 
and G proteins as mediators of platelet activation. Adv Exp Med Biol. 1993; 344:17–36. [PubMed: 
8209785] 
46. Billington CK, Penn RB. Signaling and regulation of G protein-coupled receptors in airway 
smooth muscle. Respir Res. 2003; 4:2. [PubMed: 12648290] 
47. Chen M, Gavrilova O, Liu J, Xie T, Deng C, Nguyen AT, Nackers LM, Lorenzo J, Shen L, 
Weinstein LS. Alternative Gnas gene products have opposite effects on glucose and lipid 
metabolism. Proc Natl Acad Sci U S A. 2005; 102:7386–91. [PubMed: 15883378] 
48. Hui X, Reither G, Kaestner L, Lipp P. Targeted activation of conventional and novel protein 
kinases C through differential translocation patterns. Mol Cell Biol. 2014; 34:2370–81. [PubMed: 
24732802] 
49. Verrall S, Ishii M, Chen M, Wang L, Tram T, Coughlin SR. The thrombin receptor second 
cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional 
evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-
coupled receptors. J Biol Chem. 1997; 272:6898–902. [PubMed: 9054376] 
50. Gschwendt M. Protein kinase C delta. Eur J Biochem. 1999; 259:555–64. [PubMed: 10092837] 
51. Hirai T, Chida K. Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J 
Biochem. 2003; 133:1–7. [PubMed: 12761192] 
52. Takasu H, Guo J, Bringhurst FR. Dual signaling and ligand selectivity of the human PTH/PTHrP 
receptor. J Bone Miner Res. 1999; 14:11–20. [PubMed: 9893061] 
53. Eaton SA, Williamson CM, Ball ST, Beechey CV, Moir L, Edwards J, Teboul L, Maconochie M, 
Peters J. New mutations at the imprinted Gnas cluster show gene dosage effects of Gsalpha in 
postnatal growth and implicate XLalphas in bone and fat metabolism but not in suckling. Mol Cell 
Biol. 2012; 32:1017–29. [PubMed: 22215617] 
54. He Q, Yang X, Gong Y, Kovalenko D, Canalis E, Rosen CJ, Friesel RE. Deficiency of Sef is 
associated with increased postnatal cortical bone mass by regulating Runx2 activity. J Bone Miner 
Res. 2014; 29:1217–31. [PubMed: 24127237] 
He et al. Page 15
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
55. Biber J, Stieger B, Stange G, Murer H. Isolation of renal proximal tubular brush-border 
membranes. Nat Protoc. 2007; 2:1356–9. [PubMed: 17545973] 
56. Masuda M, Yamamoto H, Kozai M, Tanaka S, Ishiguro M, Takei Y, Nakahashi O, Ikeda S, 
Uebanso T, Taketani Y, Segawa H, Miyamoto K, Takeda E. Regulation of renal sodium-
dependent phosphate co-transporter genes (Npt2a and Npt2c) by all-trans-retinoic acid and its 
receptors. Biochem J. 2010; 429:583–92. [PubMed: 20507281] 
57. Doctor RB, Chen J, Peters LL, Lux SE, Mandel LJ. Distribution of epithelial ankyrin (Ank3) 
spliceoforms in renal proximal and distal tubules. Am J Physiol. 1998; 274:F129–38. [PubMed: 
9458832] 
58. Carter PH, Dean T, Bhayana B, Khatri A, Rajur R, Gardella TJ. Actions of the Small Molecule 
Ligands SW106 and AH-3960 on the Type-1 Parathyroid Hormone Receptor. Mol Endocrinol. 
2015; 29:307–21. [PubMed: 25584411] 
59. Yang D, Guo J, Divieti P, Bringhurst FR. Parathyroid hormone activates PKC-delta and regulates 
osteoblastic differentiation via a PLC-independent pathway. Bone. 2006; 38:485–96. [PubMed: 
16325485] 
He et al. Page 16
Sci Signal. Author manuscript; available in PMC 2016 February 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 1. XLαs is located in renal proximal tubules and distal tubules at early postnatal stages
(A) Immunofluorescence staining of XLαs in kidneys taken from P2 wild-type (WT) and 
XLKO (KO) mice. XLαs is shown in red, phalloidin (to stain F-actin) is in green, and nuclei 
are in blue. Asterisks indicate glomeruli. Scale bar: 20 μm. (B) Immunofluorescence staining 
of XLαs and the Ca2+-binding protein Calbindin D-28K in kidneys taken from P2 WT and 
XLKO mice. XLαs is shown in red, Calbindin D-28K is shown in green, and nuclei are in 
blue. Arrows indicate distal tubules that are positive for Calbindin D-28K staining. Scale 
bar: 40 μm. Images in all panels are representative of three independent experiments.
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Fig. 2. P2 XLKO mice have increased amounts of Cyp27b1 and Cyp24a1 mRNAs and Npt2a 
protein
(A and B) Whole kidneys from WT and XLKO mice were processed and then analyzed by 
qRT-PCR to determine the relative amounts of (A) Cyp27b1 and (B) Cyp24a1 mRNAs. 
Data are means ± SEM of littermates from three independent litters (n = 12 mice per group). 
**P < 0.01, ***P < 0.001. (C) Renal brush-border membranes isolated from WT and XLKO 
mice were subjected to Western blotting analysis to detect Npt2a protein. Villin was used as 
a loading control. Western blots are representative of three independent experiments. (D) 
Densitometric analysis of the relative abundance of Npt2a protein normalized to that of 
villin in WT and XLKO from the experiments represented in (C). Data are means ± SEM of 
seven mice from each group. **P < 0.01.
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Fig. 3. P2 XLKO mice exhibit resistance to PTH
(A and B) P2 WT and XLKO littermate mice were injected s.c. with vehicle (10 to 12 mice 
per group) or PTH (50 nmol/kg, six mice per group). Two hours later, the mice were 
subjected to (A) qRT-PCR analysis of the relative abundance of Cyp27b1 mRNA in P2 
kidneys and (B) analysis of the serum concentrations of phosphate. Data are means ± SEM 
of four independent experiments. **P < 0.01; NS, not significant. (C) P2 WT and XLKO 
littermate mice were injected s.c. with vehicle or PTH (50 nmol/kg). Fifteen minutes later, 
renal brush-border membranes were isolated and subjected to Western blotting analysis of 
Npt2a protein. Villin was used as a loading control. Western blots are representative of four 
independent experiments. (D) Densitometric analysis of the relative abundance of Npt2a 
protein normalized to that of villin in WT and XLKO mice from the experiments 
represented in (C). Data are means ± SEM of six or seven mice from each group. *P < 0.05, 
**P < 0.01. (E) Extent of the PTH-induced reduction in Npt2a abundance in the indicated 
WT and XLKO mice relative to that in vehicle-treated mice. Data are means ± SEM of three 
independent experiments. *P < 0.05.
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Fig. 4. Gαs abundance in proximal tubules and PTH-induced concentrations of urinary cAMP 
are increased in P2 XLKO mice
(A) P2 XLKO and WT littermate mice were injected s.c. with vehicle or PTH (50 nmol/kg). 
Fifteen minutes later, the concentrations of cAMP in the urine of the mice were determined 
and expressed relative to the amounts of urinary creatinine. Data are means ± SEM of six to 
nine mice per group from three independent experiments. *P < 0.05; ***P < 0.001; NS, not 
significant. (B) Whole kidneys from P2 WT and XLKO mice were subjected to qRT-PCR 
analysis to determine the relative amounts of Gsα mRNA. Data are means ± SEM of 12 
mice per group from four independent experiments. **P < 0.01. (C) Renal brush-border 
membranes isolated from WT and XLKO mice were subjected to Western blotting analysis 
with an antibody that recognizes both Gαs and XLαs, as indicated. Villin was used a loading 
control. (D) Densitometric analysis of the relative abundance of Gαs protein normalized to 
that of villin in WT and XLKO mice from the experiments represented in (C). Data are 
means ± SEM of four mice from each group. **P < 0.01.
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Fig. 5. Basal and PTH-stimulated Gq/11 signaling is suppressed in P2 XLKO mice
(A) Proximal tubule–enriched renal cortices isolated from P2 WT and XLKO littermate 
mice were left untreated or were treated with the indicated concentrations of PTH for 30 
min. IP1 concentrations were then determined as described in the Materials and Methods. 
Data are means ± SEM of eight mice per group from two independent experiments. (B) 
Proximal tubule–enriched cortices isolated from P2 WT or XLKO mice were left untreated 
or were treated with PTH for 30 min. Samples were then subjected to fractionation, and the 
indicated membrane and cytosolic fractions were subjected to Western blotting analysis with 
antibodies specific for the indicated proteins. Western blots are representative of three 
independent experiments that combined samples from four to five pups of each genotype. (C 
to E) Densitometric analysis of the relative abundances of (C) PKCδ, (D) PKCα, and (E) 
PKCζ proteins in the membrane and cytosolic fractions of the indicated mice from the 
experiments represented in (B). Data are means ± SEM of three independent experiments. 
*P < 0.05, **P < 0.01, ***P < 0.001; NS, not significant.
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Fig. 6. Transgenic overexpression of XLαs specifically in proximal tubules rescues the phenotype 
of P2 XLKO mice
(A) Whole kidneys from P2 WT and rptXLαs (Tg) littermate mice were analyzed by qRT-
PCR to determine the relative abundance of XLαs mRNA. Data are means ± SEM of four 
independent experiments. (B) Serum phosphate concentrations in P2 WT, XLKO, rptXLαs 
(Tg), and XLKO:rptXLαs (Tg+KO) littermate mice. Data are means ± SEM of 12 to 15 
mice per group from seven litters. (C to E) Kidneys from the indicated P2 littermate mice 
were subjected to qRT-PCR analysis to determine the relative abundances of (C) Cyp27b1, 
(D) Cyp24a1, and (E) Kid1 mRNAs. Data are means ± SEM of six mice per group from 
three litters. (F) Kidneys from the indicated P2 littermate mice were subjected to subcellular 
fractionation and Western blotting analysis with antibodies against the indicated proteins. 
Western blots are representative of three independent experiments. (G to I) Densitometric 
analysis of the relative abundances of (G) PKCδ, (H) PKCα, and (I) PKCζ proteins in the 
membrane and cytosolic fractions of the indicated mice from the experiments represented in 
(F). Data are means ± SEM of four to five mice per group combined from three independent 
experiments.
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Fig. 7. Overexpression of XLαs induces basal and agonist-stimulated generation of IP3
(A) Proximal tubule–enriched cortices isolated from P2 WT and rptXLαs (Tg) littermate 
mice were left untreated or were treated with the indicated concentrations of PTH before 
being analyzed to determine the amounts of IP1. Data are means ± SEM of eight mice per 
group from three independent experiments. (B) HEK 293 cells transfected with control 
plasmid (pcDNA) or with increasing concentrations of plasmid encoding XLαs were 
analyzed to determine their IP1 concentrations under unstimulated (basal) conditions. Data 
are means ± SEM of eight experiments. #P < 0.05 between group 1 and group 2; &P < 0.05 
between group 2 and groups 3 and 4; $P < 0.05 between group 5 and groups 3 and 4. (C) 
HEK 293 cells stably expressing PTHR were transfected with control plasmid (pcDNA) or 
with plasmid encoding XLαs and then were left untreated or were treated with the indicated 
concentrations of PTH for 30 min. Samples were analyzed to determine the amounts of IP1. 
Data are means ± SEM of eight samples per group from four experiments. Inset: The same 
data presented with a different y-axis scale for the lower concentrations of PTH. (D) HEK 
293 cells transfected with control plasmid or plasmid encoding XLαs were left untreated or 
were treated with thrombin (1 U/ml) for 30 min before being subjected to IP1 analysis. Data 
are means ± SEM of eight samples per group from four experiments. (E and F) HEK 293 
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cells transfected with control plasmid or with plasmids encoding WT XLαs or the XLαs-
R543H mutant were analyzed to determine the relative amounts of (E) cAMP and (F) IP1 
under basal conditions. Data are means ± SEM of 12 samples per group from four 
independent experiments. #P < 0.05 when comparing between pcDNA-transfected cells and 
cells expressing WT XLαs; &P < 0.05 when comparing between cells expressing WT XLαs 
and cells expressing XLαs-R543H. (G and H) WT HEK 293 cells (G) and Gq/11–/– HEK 
293 cells (H) were transiently transfected with control plasmid (pcDNA) or with plasmids 
encoding XLαs, Gq, or G11, as indicated. The cells were then left unstimulated or were 
stimulated with thrombin (1 U/ml) for 30 min before being analyzed to determine their 
amounts of IP1. Data are means ± SEM of 12 samples per group from four independent 
experiments. **P < 0.01, ***P < 0.001; NS, not significant.
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Table 1
Comparison of serum biochemistries.
WT XLKO
Phosphate (mg/dl) 10.32 ± 0.24 11.42 ± 0.41*
Ca2+ (mmol/l) 1.48 ± 0.01 1.42 ± 0.02*
PTH (pg/ml) 65.25 ± 1.34 138.10 ± 4.99*
1,25(OH)2D (pmol/l) 183.42 ± 4.64 378.02 ± 6.86***
FGF23 (pg/ml) 524.11 ± 11.64 158.86 ± 9.29***
**P < 0.01
Analysis of the serum concentrations of phosphate, Ca2+, PTH, 1,25(OH)2D, and FGF23 in P2 WT and XLKO mice. Data are means ± SEM of 18 
to 27 (WT) or 14 to 20 (XLKO) mice combined from four to seven litters.
*
P < 0.05
***
P < 0.001.
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